Experts say some doctors who prescribed the powerful antibiotic rifampicin in the United States for flu-related complications are at risk for infection.
The Centers for Disease Control and Prevention reported Monday that antibiotics prescribed to US healthcare workers for flu complications such as pneumonia and pneumonia-like illness could be infecting patients in a small number of cases.
The CDC said it had found at least 17 cases of antibiotic-associated bloodstream infections in healthcare workers in the U.S. during the past two years.
Some of those infections are linked to antibiotic prescriptions and use, the CDC said.
The agency has called on doctors and healthcare workers to report the cases to the CDC.
The agency also said that doctors are encouraged to check with their patients about the potential risk to them.
The use of antibiotics for flu and other chronic conditions, including pneumonia, can increase the risk of bloodstream infections, the agency said.
Rifampin is used to treat a bacterial infection called rifaroxime that affects the respiratory tract.RIFAMPIN HAS BEEN A PROBLEM FOR MEDICINE AND DRUG AUTHORITIESSince the outbreak in late 2016, antibiotic prescriptions have soared in the health care sector, leading to a rise in antibiotic use in the treatment of other diseases.
Antibiotics are not only used in flu treatment, but also in other illnesses, such as chronic infections such as diabetes.
The FDA, which oversees antibiotic prescriptions, is trying to curb prescription abuse.
The drug is widely prescribed for infections caused by the coronavirus.
Antidepressants have also been used to manage depression.
Antiviral drugs are also widely prescribed to treat flu and severe flu.CDC Director Dr. Anthony Fauci said the CDC is working to find out more about the risk.
He said the risk to doctors is “unusual,” and the CDC will review the report.
The report comes as Congress is weighing a bill to extend the Medicare drug benefit, which pays for most healthcare treatments.
Some lawmakers have expressed concerns that expanding the benefit could lead to more drug abuse, as doctors would have less incentive to prescribe the medication.
Antifungal drugs, used to kill bacteria in a way that doesn’t cause side effects, have also emerged as an issue.
The US Food and Drug Administration is investigating whether some of the drugs are addictive.
The bill was passed by the House and Senate and is expected to be considered in the Senate by the end of the year.
The House and the Senate have also passed bills to help cover some of these costs.